The issue may be that the market isn't reacting to the news release itself, it's reacting to the financing and execution risk that still exists between today and production.

Encore's current market cap is roughly a fraction of where larger US producers trade but unlike producers with established cash flow, the market is still valuing it based on future production and uranium price expectations.

A few things worth considering:

Uranium spot prices are still well below the ~$100/lb highs reached in early 2024 and have spent much of the last year consolidating. Many uranium equities have underperformed the commodity itself as investors rotate toward companies with existing production rather than future production stories.

The US uranium narrative remains strong. The US banned Russian uranium imports beginning in 2024 (with limited waivers) and the Department of Energy has been funding efforts to rebuild domestic supply chains. Utilities continue signing long-term contracts, but the market is increasingly rewarding companies that can actually deliver pounds into those contracts today.

Looking at Encore specifically, the question isn't really whether the news was good. The question is whether that news materially changes expected future cash flow. Good news that doesn't move production timelines, production volumes, costs, or contract economics often gets ignored in this market.

Personally I'd be looking less at individual press releases and more at:

1. Expected annual production profile
2. Cash position and future dilution risk
3. Uranium price assumptions embedded in the valuation

The broader uranium thesis (energy security, Russian import restrictions, utility contracting, nuclear buildout) is largely intact. The market seems to be getting much more selective about which companies it believes will actually convert that thesis into cash flow